▲ SIGMATERMINAL Open Terminal →

Analyses / KO

KO Coca-Cola Co As of Jul 30, 2026
$89.08

Large-cap defensive consumer staple with strong margins, modest growth, elevated valuation, and 2.4% yield.

Setup: Value / Income Confidence: 65 Horizon: 12 months Risk: medium Category: Large Cap
🔒 Trade Plan — entry · target · stop
Entry Zone
$•••–•••
Target
$•••
Stop Loss
$•••
Risk / Reward
•.• : 1
Unlock the exact levels — free →

A free account reveals KO's entry zone, price target & stop loss. Full 1-week to 1-year price forecasts are included with Pro.

The Thesis

▲ Bull Case

Strong operating margins (30%), reliable EPS growth (11.5% YoY, 11.1% 5Y CAGR), 2.4% dividend yield with 67% payout ratio, recent earnings beat with guidance raise, low beta (0.33) offers defensive stability, brand moat and pricing power in inflationary environment.

▼ Bear Case

Valuation stretched: P/E 27.1x (27.1) vs S&P median ~18x, forward P/E 29.6x, EV/EBITDA 27.2x, price-to-FCF 73.3x are well above historical norms. Revenue growth only 3.7% YoY and 7.8% 5Y—slower than peers. High payout ratio (67%) limits reinvestment. Stock at 52-week high; limited margin of safety.

Valuation

OVERVALUED — score 35/100

All major valuation multiples (P/E 27.1x, forward PE 29.6x, EV/EBITDA 27.2x, P/FCF 73.3x) exceed industry and S&P 500 medians by 50–300%. Stock trading at 52-week highs with limited margin of safety. EPS growth (11.5% YoY) does not justify premium multiples given slow revenue expansion (3.7% YoY). Fair-value entry would be 15–20% lower; current price suitable only for dividend-focused, low-risk-tolerance investors.

Technical Levels

Support · $87.50 (Recent consolidation base; entry zone lower bound) · $83.00 (Entry zone low; key technical support) · $81.00 (Stop-loss level; break below suggests broader weakness)

Resistance · $90.92 (52-week high; immediate resistance) · $93.50 (Psychological / gap-fill resistance) · $97.00 (Longer-term resistance; 1-year target)

RSI: Not provided in data.

Financial Health

Score 78/100. Strong liquidity (current 1.46, quick 1.14) and scale ($383B market cap) reflect fortress balance sheet. Debt-to-equity and interest coverage not available in payload, but history suggests conservative leverage befitting Dividend Aristocrat. High payout ratio (67%) is manageable for cash-generative business with modest reinvestment needs.

Risk Flags

Valuation multiples (P/E 27x, EV/EBITDA 27x, P/FCF 73x) are elevated for a low-growth business; limited margin of safety at current price.
Revenue growth (3.7% YoY) lags beverage sector; reliance on price increases vs volume expansion may face headwinds if consumer spending weakens.
Insider activity slightly net-negative: 62 sells vs 58 buys over recent window; not alarming but mixed signal.
High payout ratio (67%) reduces flexibility for acquisitions or buybacks; dividend dependent on consistent earnings.
PEG ratio not available; cannot assess growth-adjusted valuation relative to earnings expansion.

See KO's full trade plan — free

Create a free account to unlock the exact entry, target, and stop — plus run live analysis on any of 5,000+ tickers. No card required.

Unlock KO free →

Recent News

More Analyses

KO FAQ

Is KO a buy right now?

Coca-Cola Co's current read is a Value / Income setup with 65 confidence over a 12 months horizon. Valuation: OVERVALUED. See the full bull and bear case above, or run a live analysis for the exact entry, target and stop.

Is KO overvalued?

OVERVALUED (valuation score 35/100). All major valuation multiples (P/E 27.1x, forward PE 29.6x, EV/EBITDA 27.2x, P/FCF 73.3x) exceed industry and S&P 500 medians by 50–300%. Stock trading at 52-week highs with limited margin of safety. EPS growth (11.5% YoY) does not justify premium multiples given slow revenue expansion (3.7% YoY). Fair-value entry would be 15–20% lower; current price suitable only for dividend-focused, low-risk-tolerance investors.

What are the risks of buying KO?

Valuation stretched: P/E 27.1x (27.1) vs S&P median ~18x, forward P/E 29.6x, EV/EBITDA 27.2x, price-to-FCF 73.3x are well above historical norms. Revenue growth only 3.7% YoY and 7.8% 5Y—slower than peers. High payout ratio (67%) limits reinvestment. Stock at 52-week high; limited margin of safety.